The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear production as early as day one.

To help alleviate your symptoms of dry eye syndrome (DES), try these suggestions at home. Although no cure exists for DES, many treatments are available. For most mild cases you may only require a ...

Various prescription and over-the-counter medications can increase the risk of developing dry eye syndrome, either by directly affecting the eyes or by causing other physical changes that ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

If a person has a Part D prescription drug plan, their plan may cover prescription dry eye treatments if the medication is included in the plan’s formulary. Original Medicare does not cover OTC ...

Dry eye syndrome, a condition affecting millions of Americans each year, continues to present a frustrating challenge for ...

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

Dry eyes can sometimes cause headaches, likely because of eye strain or shared inflammatory and nerve pathways.

As more people battle screen fatigue, environmental stressors, and inflammatory conditions, a surprising number of dry eye treatments are doubling as skin boosters, offering benefits well beyond ...

Dry Eye Syndrome (DES) is increasingly prevalent due to digital screen usage and environmental factors, affecting various age groups. It stems from te ...

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms ...